Global Neurodegenerative Disease Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Neurodegenerative Disease market size was valued at US$ 6850.9 million in 2023. With growing demand in downstream market, the Neurodegenerative Disease is forecast to a readjusted size of US$ 8561.2 million by 2030 with a CAGR of 3.2% during review period.
The research report highlights the growth potential of the global Neurodegenerative Disease market. Neurodegenerative Disease are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Neurodegenerative Disease. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Neurodegenerative Disease market.
Neurodegenerative diseases are a group of disorders characterized by the progressive degeneration of the structure and function of the nervous system, leading to cognitive and motor impairments. Examples include Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS).
The market for neurodegenerative disease treatments and management is driven by the increasing prevalence of these diseases, particularly with an aging population. The market's growth is also influenced by the demand for disease-modifying therapies and symptom management options to improve the quality of life for patients.
Key Features:
The report on Neurodegenerative Disease market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Neurodegenerative Disease market. It may include historical data, market segmentation by Type (e.g., NMDA, SSRIs), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Neurodegenerative Disease market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Neurodegenerative Disease market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Neurodegenerative Disease industry. This include advancements in Neurodegenerative Disease technology, Neurodegenerative Disease new entrants, Neurodegenerative Disease new investment, and other innovations that are shaping the future of Neurodegenerative Disease.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Neurodegenerative Disease market. It includes factors influencing customer ' purchasing decisions, preferences for Neurodegenerative Disease product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Neurodegenerative Disease market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Neurodegenerative Disease market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Neurodegenerative Disease market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Neurodegenerative Disease industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Neurodegenerative Disease market.
Market Segmentation:
Neurodegenerative Disease market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Neurodegenerative Disease market size was valued at US$ 6850.9 million in 2023. With growing demand in downstream market, the Neurodegenerative Disease is forecast to a readjusted size of US$ 8561.2 million by 2030 with a CAGR of 3.2% during review period.
The research report highlights the growth potential of the global Neurodegenerative Disease market. Neurodegenerative Disease are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Neurodegenerative Disease. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Neurodegenerative Disease market.
Neurodegenerative diseases are a group of disorders characterized by the progressive degeneration of the structure and function of the nervous system, leading to cognitive and motor impairments. Examples include Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS).
The market for neurodegenerative disease treatments and management is driven by the increasing prevalence of these diseases, particularly with an aging population. The market's growth is also influenced by the demand for disease-modifying therapies and symptom management options to improve the quality of life for patients.
Key Features:
The report on Neurodegenerative Disease market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Neurodegenerative Disease market. It may include historical data, market segmentation by Type (e.g., NMDA, SSRIs), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Neurodegenerative Disease market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Neurodegenerative Disease market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Neurodegenerative Disease industry. This include advancements in Neurodegenerative Disease technology, Neurodegenerative Disease new entrants, Neurodegenerative Disease new investment, and other innovations that are shaping the future of Neurodegenerative Disease.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Neurodegenerative Disease market. It includes factors influencing customer ' purchasing decisions, preferences for Neurodegenerative Disease product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Neurodegenerative Disease market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Neurodegenerative Disease market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Neurodegenerative Disease market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Neurodegenerative Disease industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Neurodegenerative Disease market.
Market Segmentation:
Neurodegenerative Disease market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- NMDA
- SSRIs
- Dopamine Inhibitors
- Parkinson’s Disease
- Huntington Disease
- Amyotrophic Lateral Sclerosis
- Alzheimer’s Disease
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novartis
- Pfizer
- Merck Serono
- Biogen Idec
- TEVA
- UCB
- Boehringer Ingelheim
- Sanofi
- GlaxoSmithKline
- Livzon Pharmaceutical
- Haisco Pharmaceutical
- Jingxin Pharmaceutical
- Dongcheng Biochemicals
- Hisun Pharmaceutical
- Luye Pharma
- Ark Pharmaceutical
- Kanghong Pharmaceutical
- Huahai Pharmaceutical
- BORA PHARMACEUTICALS
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Neurodegenerative Disease Market Size 2019-2030
2.1.2 Neurodegenerative Disease Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Neurodegenerative Disease Segment by Type
2.2.1 NMDA
2.2.2 SSRIs
2.2.3 Dopamine Inhibitors
2.3 Neurodegenerative Disease Market Size by Type
2.3.1 Neurodegenerative Disease Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Neurodegenerative Disease Market Size Market Share by Type (2019-2024)
2.4 Neurodegenerative Disease Segment by Application
2.4.1 Parkinson’s Disease
2.4.2 Huntington Disease
2.4.3 Amyotrophic Lateral Sclerosis
2.4.4 Alzheimer’s Disease
2.5 Neurodegenerative Disease Market Size by Application
2.5.1 Neurodegenerative Disease Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Neurodegenerative Disease Market Size Market Share by Application (2019-2024)
3 NEURODEGENERATIVE DISEASE MARKET SIZE BY PLAYER
3.1 Neurodegenerative Disease Market Size Market Share by Players
3.1.1 Global Neurodegenerative Disease Revenue by Players (2019-2024)
3.1.2 Global Neurodegenerative Disease Revenue Market Share by Players (2019-2024)
3.2 Global Neurodegenerative Disease Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NEURODEGENERATIVE DISEASE BY REGIONS
4.1 Neurodegenerative Disease Market Size by Regions (2019-2024)
4.2 Americas Neurodegenerative Disease Market Size Growth (2019-2024)
4.3 APAC Neurodegenerative Disease Market Size Growth (2019-2024)
4.4 Europe Neurodegenerative Disease Market Size Growth (2019-2024)
4.5 Middle East & Africa Neurodegenerative Disease Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Neurodegenerative Disease Market Size by Country (2019-2024)
5.2 Americas Neurodegenerative Disease Market Size by Type (2019-2024)
5.3 Americas Neurodegenerative Disease Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neurodegenerative Disease Market Size by Region (2019-2024)
6.2 APAC Neurodegenerative Disease Market Size by Type (2019-2024)
6.3 APAC Neurodegenerative Disease Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Neurodegenerative Disease by Country (2019-2024)
7.2 Europe Neurodegenerative Disease Market Size by Type (2019-2024)
7.3 Europe Neurodegenerative Disease Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Neurodegenerative Disease by Region (2019-2024)
8.2 Middle East & Africa Neurodegenerative Disease Market Size by Type (2019-2024)
8.3 Middle East & Africa Neurodegenerative Disease Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NEURODEGENERATIVE DISEASE MARKET FORECAST
10.1 Global Neurodegenerative Disease Forecast by Regions (2025-2030)
10.1.1 Global Neurodegenerative Disease Forecast by Regions (2025-2030)
10.1.2 Americas Neurodegenerative Disease Forecast
10.1.3 APAC Neurodegenerative Disease Forecast
10.1.4 Europe Neurodegenerative Disease Forecast
10.1.5 Middle East & Africa Neurodegenerative Disease Forecast
10.2 Americas Neurodegenerative Disease Forecast by Country (2025-2030)
10.2.1 United States Neurodegenerative Disease Market Forecast
10.2.2 Canada Neurodegenerative Disease Market Forecast
10.2.3 Mexico Neurodegenerative Disease Market Forecast
10.2.4 Brazil Neurodegenerative Disease Market Forecast
10.3 APAC Neurodegenerative Disease Forecast by Region (2025-2030)
10.3.1 China Neurodegenerative Disease Market Forecast
10.3.2 Japan Neurodegenerative Disease Market Forecast
10.3.3 Korea Neurodegenerative Disease Market Forecast
10.3.4 Southeast Asia Neurodegenerative Disease Market Forecast
10.3.5 India Neurodegenerative Disease Market Forecast
10.3.6 Australia Neurodegenerative Disease Market Forecast
10.4 Europe Neurodegenerative Disease Forecast by Country (2025-2030)
10.4.1 Germany Neurodegenerative Disease Market Forecast
10.4.2 France Neurodegenerative Disease Market Forecast
10.4.3 UK Neurodegenerative Disease Market Forecast
10.4.4 Italy Neurodegenerative Disease Market Forecast
10.4.5 Russia Neurodegenerative Disease Market Forecast
10.5 Middle East & Africa Neurodegenerative Disease Forecast by Region (2025-2030)
10.5.1 Egypt Neurodegenerative Disease Market Forecast
10.5.2 South Africa Neurodegenerative Disease Market Forecast
10.5.3 Israel Neurodegenerative Disease Market Forecast
10.5.4 Turkey Neurodegenerative Disease Market Forecast
10.5.5 GCC Countries Neurodegenerative Disease Market Forecast
10.6 Global Neurodegenerative Disease Forecast by Type (2025-2030)
10.7 Global Neurodegenerative Disease Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis Neurodegenerative Disease Product Offered
11.1.3 Novartis Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Novartis Main Business Overview
11.1.5 Novartis Latest Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Neurodegenerative Disease Product Offered
11.2.3 Pfizer Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Pfizer Main Business Overview
11.2.5 Pfizer Latest Developments
11.3 Merck Serono
11.3.1 Merck Serono Company Information
11.3.2 Merck Serono Neurodegenerative Disease Product Offered
11.3.3 Merck Serono Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Merck Serono Main Business Overview
11.3.5 Merck Serono Latest Developments
11.4 Biogen Idec
11.4.1 Biogen Idec Company Information
11.4.2 Biogen Idec Neurodegenerative Disease Product Offered
11.4.3 Biogen Idec Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Biogen Idec Main Business Overview
11.4.5 Biogen Idec Latest Developments
11.5 TEVA
11.5.1 TEVA Company Information
11.5.2 TEVA Neurodegenerative Disease Product Offered
11.5.3 TEVA Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 TEVA Main Business Overview
11.5.5 TEVA Latest Developments
11.6 UCB
11.6.1 UCB Company Information
11.6.2 UCB Neurodegenerative Disease Product Offered
11.6.3 UCB Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 UCB Main Business Overview
11.6.5 UCB Latest Developments
11.7 Boehringer Ingelheim
11.7.1 Boehringer Ingelheim Company Information
11.7.2 Boehringer Ingelheim Neurodegenerative Disease Product Offered
11.7.3 Boehringer Ingelheim Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Boehringer Ingelheim Main Business Overview
11.7.5 Boehringer Ingelheim Latest Developments
11.8 Sanofi
11.8.1 Sanofi Company Information
11.8.2 Sanofi Neurodegenerative Disease Product Offered
11.8.3 Sanofi Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Sanofi Main Business Overview
11.8.5 Sanofi Latest Developments
11.9 GlaxoSmithKline
11.9.1 GlaxoSmithKline Company Information
11.9.2 GlaxoSmithKline Neurodegenerative Disease Product Offered
11.9.3 GlaxoSmithKline Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 GlaxoSmithKline Main Business Overview
11.9.5 GlaxoSmithKline Latest Developments
11.10 Livzon Pharmaceutical
11.10.1 Livzon Pharmaceutical Company Information
11.10.2 Livzon Pharmaceutical Neurodegenerative Disease Product Offered
11.10.3 Livzon Pharmaceutical Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Livzon Pharmaceutical Main Business Overview
11.10.5 Livzon Pharmaceutical Latest Developments
11.11 Haisco Pharmaceutical
11.11.1 Haisco Pharmaceutical Company Information
11.11.2 Haisco Pharmaceutical Neurodegenerative Disease Product Offered
11.11.3 Haisco Pharmaceutical Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Haisco Pharmaceutical Main Business Overview
11.11.5 Haisco Pharmaceutical Latest Developments
11.12 Jingxin Pharmaceutical
11.12.1 Jingxin Pharmaceutical Company Information
11.12.2 Jingxin Pharmaceutical Neurodegenerative Disease Product Offered
11.12.3 Jingxin Pharmaceutical Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Jingxin Pharmaceutical Main Business Overview
11.12.5 Jingxin Pharmaceutical Latest Developments
11.13 Dongcheng Biochemicals
11.13.1 Dongcheng Biochemicals Company Information
11.13.2 Dongcheng Biochemicals Neurodegenerative Disease Product Offered
11.13.3 Dongcheng Biochemicals Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Dongcheng Biochemicals Main Business Overview
11.13.5 Dongcheng Biochemicals Latest Developments
11.14 Hisun Pharmaceutical
11.14.1 Hisun Pharmaceutical Company Information
11.14.2 Hisun Pharmaceutical Neurodegenerative Disease Product Offered
11.14.3 Hisun Pharmaceutical Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Hisun Pharmaceutical Main Business Overview
11.14.5 Hisun Pharmaceutical Latest Developments
11.15 Luye Pharma
11.15.1 Luye Pharma Company Information
11.15.2 Luye Pharma Neurodegenerative Disease Product Offered
11.15.3 Luye Pharma Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Luye Pharma Main Business Overview
11.15.5 Luye Pharma Latest Developments
11.16 Ark Pharmaceutical
11.16.1 Ark Pharmaceutical Company Information
11.16.2 Ark Pharmaceutical Neurodegenerative Disease Product Offered
11.16.3 Ark Pharmaceutical Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Ark Pharmaceutical Main Business Overview
11.16.5 Ark Pharmaceutical Latest Developments
11.17 Kanghong Pharmaceutical
11.17.1 Kanghong Pharmaceutical Company Information
11.17.2 Kanghong Pharmaceutical Neurodegenerative Disease Product Offered
11.17.3 Kanghong Pharmaceutical Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Kanghong Pharmaceutical Main Business Overview
11.17.5 Kanghong Pharmaceutical Latest Developments
11.18 Huahai Pharmaceutical
11.18.1 Huahai Pharmaceutical Company Information
11.18.2 Huahai Pharmaceutical Neurodegenerative Disease Product Offered
11.18.3 Huahai Pharmaceutical Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Huahai Pharmaceutical Main Business Overview
11.18.5 Huahai Pharmaceutical Latest Developments
11.19 BORA PHARMACEUTICALS
11.19.1 BORA PHARMACEUTICALS Company Information
11.19.2 BORA PHARMACEUTICALS Neurodegenerative Disease Product Offered
11.19.3 BORA PHARMACEUTICALS Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 BORA PHARMACEUTICALS Main Business Overview
11.19.5 BORA PHARMACEUTICALS Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Neurodegenerative Disease Market Size 2019-2030
2.1.2 Neurodegenerative Disease Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Neurodegenerative Disease Segment by Type
2.2.1 NMDA
2.2.2 SSRIs
2.2.3 Dopamine Inhibitors
2.3 Neurodegenerative Disease Market Size by Type
2.3.1 Neurodegenerative Disease Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Neurodegenerative Disease Market Size Market Share by Type (2019-2024)
2.4 Neurodegenerative Disease Segment by Application
2.4.1 Parkinson’s Disease
2.4.2 Huntington Disease
2.4.3 Amyotrophic Lateral Sclerosis
2.4.4 Alzheimer’s Disease
2.5 Neurodegenerative Disease Market Size by Application
2.5.1 Neurodegenerative Disease Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Neurodegenerative Disease Market Size Market Share by Application (2019-2024)
3 NEURODEGENERATIVE DISEASE MARKET SIZE BY PLAYER
3.1 Neurodegenerative Disease Market Size Market Share by Players
3.1.1 Global Neurodegenerative Disease Revenue by Players (2019-2024)
3.1.2 Global Neurodegenerative Disease Revenue Market Share by Players (2019-2024)
3.2 Global Neurodegenerative Disease Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NEURODEGENERATIVE DISEASE BY REGIONS
4.1 Neurodegenerative Disease Market Size by Regions (2019-2024)
4.2 Americas Neurodegenerative Disease Market Size Growth (2019-2024)
4.3 APAC Neurodegenerative Disease Market Size Growth (2019-2024)
4.4 Europe Neurodegenerative Disease Market Size Growth (2019-2024)
4.5 Middle East & Africa Neurodegenerative Disease Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Neurodegenerative Disease Market Size by Country (2019-2024)
5.2 Americas Neurodegenerative Disease Market Size by Type (2019-2024)
5.3 Americas Neurodegenerative Disease Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neurodegenerative Disease Market Size by Region (2019-2024)
6.2 APAC Neurodegenerative Disease Market Size by Type (2019-2024)
6.3 APAC Neurodegenerative Disease Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Neurodegenerative Disease by Country (2019-2024)
7.2 Europe Neurodegenerative Disease Market Size by Type (2019-2024)
7.3 Europe Neurodegenerative Disease Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Neurodegenerative Disease by Region (2019-2024)
8.2 Middle East & Africa Neurodegenerative Disease Market Size by Type (2019-2024)
8.3 Middle East & Africa Neurodegenerative Disease Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NEURODEGENERATIVE DISEASE MARKET FORECAST
10.1 Global Neurodegenerative Disease Forecast by Regions (2025-2030)
10.1.1 Global Neurodegenerative Disease Forecast by Regions (2025-2030)
10.1.2 Americas Neurodegenerative Disease Forecast
10.1.3 APAC Neurodegenerative Disease Forecast
10.1.4 Europe Neurodegenerative Disease Forecast
10.1.5 Middle East & Africa Neurodegenerative Disease Forecast
10.2 Americas Neurodegenerative Disease Forecast by Country (2025-2030)
10.2.1 United States Neurodegenerative Disease Market Forecast
10.2.2 Canada Neurodegenerative Disease Market Forecast
10.2.3 Mexico Neurodegenerative Disease Market Forecast
10.2.4 Brazil Neurodegenerative Disease Market Forecast
10.3 APAC Neurodegenerative Disease Forecast by Region (2025-2030)
10.3.1 China Neurodegenerative Disease Market Forecast
10.3.2 Japan Neurodegenerative Disease Market Forecast
10.3.3 Korea Neurodegenerative Disease Market Forecast
10.3.4 Southeast Asia Neurodegenerative Disease Market Forecast
10.3.5 India Neurodegenerative Disease Market Forecast
10.3.6 Australia Neurodegenerative Disease Market Forecast
10.4 Europe Neurodegenerative Disease Forecast by Country (2025-2030)
10.4.1 Germany Neurodegenerative Disease Market Forecast
10.4.2 France Neurodegenerative Disease Market Forecast
10.4.3 UK Neurodegenerative Disease Market Forecast
10.4.4 Italy Neurodegenerative Disease Market Forecast
10.4.5 Russia Neurodegenerative Disease Market Forecast
10.5 Middle East & Africa Neurodegenerative Disease Forecast by Region (2025-2030)
10.5.1 Egypt Neurodegenerative Disease Market Forecast
10.5.2 South Africa Neurodegenerative Disease Market Forecast
10.5.3 Israel Neurodegenerative Disease Market Forecast
10.5.4 Turkey Neurodegenerative Disease Market Forecast
10.5.5 GCC Countries Neurodegenerative Disease Market Forecast
10.6 Global Neurodegenerative Disease Forecast by Type (2025-2030)
10.7 Global Neurodegenerative Disease Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis Neurodegenerative Disease Product Offered
11.1.3 Novartis Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Novartis Main Business Overview
11.1.5 Novartis Latest Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Neurodegenerative Disease Product Offered
11.2.3 Pfizer Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Pfizer Main Business Overview
11.2.5 Pfizer Latest Developments
11.3 Merck Serono
11.3.1 Merck Serono Company Information
11.3.2 Merck Serono Neurodegenerative Disease Product Offered
11.3.3 Merck Serono Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Merck Serono Main Business Overview
11.3.5 Merck Serono Latest Developments
11.4 Biogen Idec
11.4.1 Biogen Idec Company Information
11.4.2 Biogen Idec Neurodegenerative Disease Product Offered
11.4.3 Biogen Idec Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Biogen Idec Main Business Overview
11.4.5 Biogen Idec Latest Developments
11.5 TEVA
11.5.1 TEVA Company Information
11.5.2 TEVA Neurodegenerative Disease Product Offered
11.5.3 TEVA Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 TEVA Main Business Overview
11.5.5 TEVA Latest Developments
11.6 UCB
11.6.1 UCB Company Information
11.6.2 UCB Neurodegenerative Disease Product Offered
11.6.3 UCB Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 UCB Main Business Overview
11.6.5 UCB Latest Developments
11.7 Boehringer Ingelheim
11.7.1 Boehringer Ingelheim Company Information
11.7.2 Boehringer Ingelheim Neurodegenerative Disease Product Offered
11.7.3 Boehringer Ingelheim Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Boehringer Ingelheim Main Business Overview
11.7.5 Boehringer Ingelheim Latest Developments
11.8 Sanofi
11.8.1 Sanofi Company Information
11.8.2 Sanofi Neurodegenerative Disease Product Offered
11.8.3 Sanofi Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Sanofi Main Business Overview
11.8.5 Sanofi Latest Developments
11.9 GlaxoSmithKline
11.9.1 GlaxoSmithKline Company Information
11.9.2 GlaxoSmithKline Neurodegenerative Disease Product Offered
11.9.3 GlaxoSmithKline Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 GlaxoSmithKline Main Business Overview
11.9.5 GlaxoSmithKline Latest Developments
11.10 Livzon Pharmaceutical
11.10.1 Livzon Pharmaceutical Company Information
11.10.2 Livzon Pharmaceutical Neurodegenerative Disease Product Offered
11.10.3 Livzon Pharmaceutical Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Livzon Pharmaceutical Main Business Overview
11.10.5 Livzon Pharmaceutical Latest Developments
11.11 Haisco Pharmaceutical
11.11.1 Haisco Pharmaceutical Company Information
11.11.2 Haisco Pharmaceutical Neurodegenerative Disease Product Offered
11.11.3 Haisco Pharmaceutical Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Haisco Pharmaceutical Main Business Overview
11.11.5 Haisco Pharmaceutical Latest Developments
11.12 Jingxin Pharmaceutical
11.12.1 Jingxin Pharmaceutical Company Information
11.12.2 Jingxin Pharmaceutical Neurodegenerative Disease Product Offered
11.12.3 Jingxin Pharmaceutical Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Jingxin Pharmaceutical Main Business Overview
11.12.5 Jingxin Pharmaceutical Latest Developments
11.13 Dongcheng Biochemicals
11.13.1 Dongcheng Biochemicals Company Information
11.13.2 Dongcheng Biochemicals Neurodegenerative Disease Product Offered
11.13.3 Dongcheng Biochemicals Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Dongcheng Biochemicals Main Business Overview
11.13.5 Dongcheng Biochemicals Latest Developments
11.14 Hisun Pharmaceutical
11.14.1 Hisun Pharmaceutical Company Information
11.14.2 Hisun Pharmaceutical Neurodegenerative Disease Product Offered
11.14.3 Hisun Pharmaceutical Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Hisun Pharmaceutical Main Business Overview
11.14.5 Hisun Pharmaceutical Latest Developments
11.15 Luye Pharma
11.15.1 Luye Pharma Company Information
11.15.2 Luye Pharma Neurodegenerative Disease Product Offered
11.15.3 Luye Pharma Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Luye Pharma Main Business Overview
11.15.5 Luye Pharma Latest Developments
11.16 Ark Pharmaceutical
11.16.1 Ark Pharmaceutical Company Information
11.16.2 Ark Pharmaceutical Neurodegenerative Disease Product Offered
11.16.3 Ark Pharmaceutical Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Ark Pharmaceutical Main Business Overview
11.16.5 Ark Pharmaceutical Latest Developments
11.17 Kanghong Pharmaceutical
11.17.1 Kanghong Pharmaceutical Company Information
11.17.2 Kanghong Pharmaceutical Neurodegenerative Disease Product Offered
11.17.3 Kanghong Pharmaceutical Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Kanghong Pharmaceutical Main Business Overview
11.17.5 Kanghong Pharmaceutical Latest Developments
11.18 Huahai Pharmaceutical
11.18.1 Huahai Pharmaceutical Company Information
11.18.2 Huahai Pharmaceutical Neurodegenerative Disease Product Offered
11.18.3 Huahai Pharmaceutical Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Huahai Pharmaceutical Main Business Overview
11.18.5 Huahai Pharmaceutical Latest Developments
11.19 BORA PHARMACEUTICALS
11.19.1 BORA PHARMACEUTICALS Company Information
11.19.2 BORA PHARMACEUTICALS Neurodegenerative Disease Product Offered
11.19.3 BORA PHARMACEUTICALS Neurodegenerative Disease Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 BORA PHARMACEUTICALS Main Business Overview
11.19.5 BORA PHARMACEUTICALS Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Neurodegenerative Disease Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of NMDA
Table 3. Major Players of SSRIs
Table 4. Major Players of Dopamine Inhibitors
Table 5. Neurodegenerative Disease Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global Neurodegenerative Disease Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global Neurodegenerative Disease Market Size Market Share by Type (2019-2024)
Table 8. Neurodegenerative Disease Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Neurodegenerative Disease Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global Neurodegenerative Disease Market Size Market Share by Application (2019-2024)
Table 11. Global Neurodegenerative Disease Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global Neurodegenerative Disease Revenue Market Share by Player (2019-2024)
Table 13. Neurodegenerative Disease Key Players Head office and Products Offered
Table 14. Neurodegenerative Disease Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Neurodegenerative Disease Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global Neurodegenerative Disease Market Size Market Share by Regions (2019-2024)
Table 19. Global Neurodegenerative Disease Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Neurodegenerative Disease Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Neurodegenerative Disease Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas Neurodegenerative Disease Market Size Market Share by Country (2019-2024)
Table 23. Americas Neurodegenerative Disease Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas Neurodegenerative Disease Market Size Market Share by Type (2019-2024)
Table 25. Americas Neurodegenerative Disease Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas Neurodegenerative Disease Market Size Market Share by Application (2019-2024)
Table 27. APAC Neurodegenerative Disease Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC Neurodegenerative Disease Market Size Market Share by Region (2019-2024)
Table 29. APAC Neurodegenerative Disease Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC Neurodegenerative Disease Market Size Market Share by Type (2019-2024)
Table 31. APAC Neurodegenerative Disease Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC Neurodegenerative Disease Market Size Market Share by Application (2019-2024)
Table 33. Europe Neurodegenerative Disease Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe Neurodegenerative Disease Market Size Market Share by Country (2019-2024)
Table 35. Europe Neurodegenerative Disease Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe Neurodegenerative Disease Market Size Market Share by Type (2019-2024)
Table 37. Europe Neurodegenerative Disease Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe Neurodegenerative Disease Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa Neurodegenerative Disease Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa Neurodegenerative Disease Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa Neurodegenerative Disease Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Neurodegenerative Disease Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa Neurodegenerative Disease Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Neurodegenerative Disease Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of Neurodegenerative Disease
Table 46. Key Market Challenges & Risks of Neurodegenerative Disease
Table 47. Key Industry Trends of Neurodegenerative Disease
Table 48. Global Neurodegenerative Disease Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global Neurodegenerative Disease Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global Neurodegenerative Disease Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global Neurodegenerative Disease Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. Novartis Details, Company Type, Neurodegenerative Disease Area Served and Its Competitors
Table 53. Novartis Neurodegenerative Disease Product Offered
Table 54. Novartis Neurodegenerative Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Novartis Main Business
Table 56. Novartis Latest Developments
Table 57. Pfizer Details, Company Type, Neurodegenerative Disease Area Served and Its Competitors
Table 58. Pfizer Neurodegenerative Disease Product Offered
Table 59. Pfizer Main Business
Table 60. Pfizer Neurodegenerative Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Pfizer Latest Developments
Table 62. Merck Serono Details, Company Type, Neurodegenerative Disease Area Served and Its Competitors
Table 63. Merck Serono Neurodegenerative Disease Product Offered
Table 64. Merck Serono Main Business
Table 65. Merck Serono Neurodegenerative Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Merck Serono Latest Developments
Table 67. Biogen Idec Details, Company Type, Neurodegenerative Disease Area Served and Its Competitors
Table 68. Biogen Idec Neurodegenerative Disease Product Offered
Table 69. Biogen Idec Main Business
Table 70. Biogen Idec Neurodegenerative Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Biogen Idec Latest Developments
Table 72. TEVA Details, Company Type, Neurodegenerative Disease Area Served and Its Competitors
Table 73. TEVA Neurodegenerative Disease Product Offered
Table 74. TEVA Main Business
Table 75. TEVA Neurodegenerative Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. TEVA Latest Developments
Table 77. UCB Details, Company Type, Neurodegenerative Disease Area Served and Its Competitors
Table 78. UCB Neurodegenerative Disease Product Offered
Table 79. UCB Main Business
Table 80. UCB Neurodegenerative Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. UCB Latest Developments
Table 82. Boehringer Ingelheim Details, Company Type, Neurodegenerative Disease Area Served and Its Competitors
Table 83. Boehringer Ingelheim Neurodegenerative Disease Product Offered
Table 84. Boehringer Ingelheim Main Business
Table 85. Boehringer Ingelheim Neurodegenerative Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Boehringer Ingelheim Latest Developments
Table 87. Sanofi Details, Company Type, Neurodegenerative Disease Area Served and Its Competitors
Table 88. Sanofi Neurodegenerative Disease Product Offered
Table 89. Sanofi Main Business
Table 90. Sanofi Neurodegenerative Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. Sanofi Latest Developments
Table 92. GlaxoSmithKline Details, Company Type, Neurodegenerative Disease Area Served and Its Competitors
Table 93. GlaxoSmithKline Neurodegenerative Disease Product Offered
Table 94. GlaxoSmithKline Main Business
Table 95. GlaxoSmithKline Neurodegenerative Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. GlaxoSmithKline Latest Developments
Table 97. Livzon Pharmaceutical Details, Company Type, Neurodegenerative Disease Area Served and Its Competitors
Table 98. Livzon Pharmaceutical Neurodegenerative Disease Product Offered
Table 99. Livzon Pharmaceutical Main Business
Table 100. Livzon Pharmaceutical Neurodegenerative Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 101. Livzon Pharmaceutical Latest Developments
Table 102. Haisco Pharmaceutical Details, Company Type, Neurodegenerative Disease Area Served and Its Competitors
Table 103. Haisco Pharmaceutical Neurodegenerative Disease Product Offered
Table 104. Haisco Pharmaceutical Neurodegenerative Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 105. Haisco Pharmaceutical Main Business
Table 106. Haisco Pharmaceutical Latest Developments
Table 107. Jingxin Pharmaceutical Details, Company Type, Neurodegenerative Disease Area Served and Its Competitors
Table 108. Jingxin Pharmaceutical Neurodegenerative Disease Product Offered
Table 109. Jingxin Pharmaceutical Main Business
Table 110. Jingxin Pharmaceutical Neurodegenerative Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 111. Jingxin Pharmaceutical Latest Developments
Table 112. Dongcheng Biochemicals Details, Company Type, Neurodegenerative Disease Area Served and Its Competitors
Table 113. Dongcheng Biochemicals Neurodegenerative Disease Product Offered
Table 114. Dongcheng Biochemicals Main Business
Table 115. Dongcheng Biochemicals Neurodegenerative Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 116. Dongcheng Biochemicals Latest Developments
Table 117. Hisun Pharmaceutical Details, Company Type, Neurodegenerative Disease Area Served and Its Competitors
Table 118. Hisun Pharmaceutical Neurodegenerative Disease Product Offered
Table 119. Hisun Pharmaceutical Main Business
Table 120. Hisun Pharmaceutical Neurodegenerative Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 121. Hisun Pharmaceutical Latest Developments
Table 122. Luye Pharma Details, Company Type, Neurodegenerative Disease Area Served and Its Competitors
Table 123. Luye Pharma Neurodegenerative Disease Product Offered
Table 124. Luye Pharma Main Business
Table 125. Luye Pharma Neurodegenerative Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 126. Luye Pharma Latest Developments
Table 127. Ark Pharmaceutical Details, Company Type, Neurodegenerative Disease Area Served and Its Competitors
Table 128. Ark Pharmaceutical Neurodegenerative Disease Product Offered
Table 129. Ark Pharmaceutical Main Business
Table 130. Ark Pharmaceutical Neurodegenerative Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 131. Ark Pharmaceutical Latest Developments
Table 132. Kanghong Pharmaceutical Details, Company Type, Neurodegenerative Disease Area Served and Its Competitors
Table 133. Kanghong Pharmaceutical Neurodegenerative Disease Product Offered
Table 134. Kanghong Pharmaceutical Main Business
Table 135. Kanghong Pharmaceutical Neurodegenerative Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 136. Kanghong Pharmaceutical Latest Developments
Table 137. Huahai Pharmaceutical Details, Company Type, Neurodegenerative Disease Area Served and Its Competitors
Table 138. Huahai Pharmaceutical Neurodegenerative Disease Product Offered
Table 139. Huahai Pharmaceutical Main Business
Table 140. Huahai Pharmaceutical Neurodegenerative Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 141. Huahai Pharmaceutical Latest Developments
Table 142. BORA PHARMACEUTICALS Details, Company Type, Neurodegenerative Disease Area Served and Its Competitors
Table 143. BORA PHARMACEUTICALS Neurodegenerative Disease Product Offered
Table 144. BORA PHARMACEUTICALS Main Business
Table 145. BORA PHARMACEUTICALS Neurodegenerative Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 146. BORA PHARMACEUTICALS Latest Developments
Table 1. Neurodegenerative Disease Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of NMDA
Table 3. Major Players of SSRIs
Table 4. Major Players of Dopamine Inhibitors
Table 5. Neurodegenerative Disease Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global Neurodegenerative Disease Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global Neurodegenerative Disease Market Size Market Share by Type (2019-2024)
Table 8. Neurodegenerative Disease Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Neurodegenerative Disease Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global Neurodegenerative Disease Market Size Market Share by Application (2019-2024)
Table 11. Global Neurodegenerative Disease Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global Neurodegenerative Disease Revenue Market Share by Player (2019-2024)
Table 13. Neurodegenerative Disease Key Players Head office and Products Offered
Table 14. Neurodegenerative Disease Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Neurodegenerative Disease Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global Neurodegenerative Disease Market Size Market Share by Regions (2019-2024)
Table 19. Global Neurodegenerative Disease Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Neurodegenerative Disease Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Neurodegenerative Disease Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas Neurodegenerative Disease Market Size Market Share by Country (2019-2024)
Table 23. Americas Neurodegenerative Disease Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas Neurodegenerative Disease Market Size Market Share by Type (2019-2024)
Table 25. Americas Neurodegenerative Disease Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas Neurodegenerative Disease Market Size Market Share by Application (2019-2024)
Table 27. APAC Neurodegenerative Disease Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC Neurodegenerative Disease Market Size Market Share by Region (2019-2024)
Table 29. APAC Neurodegenerative Disease Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC Neurodegenerative Disease Market Size Market Share by Type (2019-2024)
Table 31. APAC Neurodegenerative Disease Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC Neurodegenerative Disease Market Size Market Share by Application (2019-2024)
Table 33. Europe Neurodegenerative Disease Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe Neurodegenerative Disease Market Size Market Share by Country (2019-2024)
Table 35. Europe Neurodegenerative Disease Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe Neurodegenerative Disease Market Size Market Share by Type (2019-2024)
Table 37. Europe Neurodegenerative Disease Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe Neurodegenerative Disease Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa Neurodegenerative Disease Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa Neurodegenerative Disease Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa Neurodegenerative Disease Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Neurodegenerative Disease Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa Neurodegenerative Disease Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Neurodegenerative Disease Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of Neurodegenerative Disease
Table 46. Key Market Challenges & Risks of Neurodegenerative Disease
Table 47. Key Industry Trends of Neurodegenerative Disease
Table 48. Global Neurodegenerative Disease Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global Neurodegenerative Disease Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global Neurodegenerative Disease Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global Neurodegenerative Disease Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. Novartis Details, Company Type, Neurodegenerative Disease Area Served and Its Competitors
Table 53. Novartis Neurodegenerative Disease Product Offered
Table 54. Novartis Neurodegenerative Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Novartis Main Business
Table 56. Novartis Latest Developments
Table 57. Pfizer Details, Company Type, Neurodegenerative Disease Area Served and Its Competitors
Table 58. Pfizer Neurodegenerative Disease Product Offered
Table 59. Pfizer Main Business
Table 60. Pfizer Neurodegenerative Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Pfizer Latest Developments
Table 62. Merck Serono Details, Company Type, Neurodegenerative Disease Area Served and Its Competitors
Table 63. Merck Serono Neurodegenerative Disease Product Offered
Table 64. Merck Serono Main Business
Table 65. Merck Serono Neurodegenerative Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Merck Serono Latest Developments
Table 67. Biogen Idec Details, Company Type, Neurodegenerative Disease Area Served and Its Competitors
Table 68. Biogen Idec Neurodegenerative Disease Product Offered
Table 69. Biogen Idec Main Business
Table 70. Biogen Idec Neurodegenerative Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Biogen Idec Latest Developments
Table 72. TEVA Details, Company Type, Neurodegenerative Disease Area Served and Its Competitors
Table 73. TEVA Neurodegenerative Disease Product Offered
Table 74. TEVA Main Business
Table 75. TEVA Neurodegenerative Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. TEVA Latest Developments
Table 77. UCB Details, Company Type, Neurodegenerative Disease Area Served and Its Competitors
Table 78. UCB Neurodegenerative Disease Product Offered
Table 79. UCB Main Business
Table 80. UCB Neurodegenerative Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. UCB Latest Developments
Table 82. Boehringer Ingelheim Details, Company Type, Neurodegenerative Disease Area Served and Its Competitors
Table 83. Boehringer Ingelheim Neurodegenerative Disease Product Offered
Table 84. Boehringer Ingelheim Main Business
Table 85. Boehringer Ingelheim Neurodegenerative Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Boehringer Ingelheim Latest Developments
Table 87. Sanofi Details, Company Type, Neurodegenerative Disease Area Served and Its Competitors
Table 88. Sanofi Neurodegenerative Disease Product Offered
Table 89. Sanofi Main Business
Table 90. Sanofi Neurodegenerative Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. Sanofi Latest Developments
Table 92. GlaxoSmithKline Details, Company Type, Neurodegenerative Disease Area Served and Its Competitors
Table 93. GlaxoSmithKline Neurodegenerative Disease Product Offered
Table 94. GlaxoSmithKline Main Business
Table 95. GlaxoSmithKline Neurodegenerative Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. GlaxoSmithKline Latest Developments
Table 97. Livzon Pharmaceutical Details, Company Type, Neurodegenerative Disease Area Served and Its Competitors
Table 98. Livzon Pharmaceutical Neurodegenerative Disease Product Offered
Table 99. Livzon Pharmaceutical Main Business
Table 100. Livzon Pharmaceutical Neurodegenerative Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 101. Livzon Pharmaceutical Latest Developments
Table 102. Haisco Pharmaceutical Details, Company Type, Neurodegenerative Disease Area Served and Its Competitors
Table 103. Haisco Pharmaceutical Neurodegenerative Disease Product Offered
Table 104. Haisco Pharmaceutical Neurodegenerative Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 105. Haisco Pharmaceutical Main Business
Table 106. Haisco Pharmaceutical Latest Developments
Table 107. Jingxin Pharmaceutical Details, Company Type, Neurodegenerative Disease Area Served and Its Competitors
Table 108. Jingxin Pharmaceutical Neurodegenerative Disease Product Offered
Table 109. Jingxin Pharmaceutical Main Business
Table 110. Jingxin Pharmaceutical Neurodegenerative Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 111. Jingxin Pharmaceutical Latest Developments
Table 112. Dongcheng Biochemicals Details, Company Type, Neurodegenerative Disease Area Served and Its Competitors
Table 113. Dongcheng Biochemicals Neurodegenerative Disease Product Offered
Table 114. Dongcheng Biochemicals Main Business
Table 115. Dongcheng Biochemicals Neurodegenerative Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 116. Dongcheng Biochemicals Latest Developments
Table 117. Hisun Pharmaceutical Details, Company Type, Neurodegenerative Disease Area Served and Its Competitors
Table 118. Hisun Pharmaceutical Neurodegenerative Disease Product Offered
Table 119. Hisun Pharmaceutical Main Business
Table 120. Hisun Pharmaceutical Neurodegenerative Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 121. Hisun Pharmaceutical Latest Developments
Table 122. Luye Pharma Details, Company Type, Neurodegenerative Disease Area Served and Its Competitors
Table 123. Luye Pharma Neurodegenerative Disease Product Offered
Table 124. Luye Pharma Main Business
Table 125. Luye Pharma Neurodegenerative Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 126. Luye Pharma Latest Developments
Table 127. Ark Pharmaceutical Details, Company Type, Neurodegenerative Disease Area Served and Its Competitors
Table 128. Ark Pharmaceutical Neurodegenerative Disease Product Offered
Table 129. Ark Pharmaceutical Main Business
Table 130. Ark Pharmaceutical Neurodegenerative Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 131. Ark Pharmaceutical Latest Developments
Table 132. Kanghong Pharmaceutical Details, Company Type, Neurodegenerative Disease Area Served and Its Competitors
Table 133. Kanghong Pharmaceutical Neurodegenerative Disease Product Offered
Table 134. Kanghong Pharmaceutical Main Business
Table 135. Kanghong Pharmaceutical Neurodegenerative Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 136. Kanghong Pharmaceutical Latest Developments
Table 137. Huahai Pharmaceutical Details, Company Type, Neurodegenerative Disease Area Served and Its Competitors
Table 138. Huahai Pharmaceutical Neurodegenerative Disease Product Offered
Table 139. Huahai Pharmaceutical Main Business
Table 140. Huahai Pharmaceutical Neurodegenerative Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 141. Huahai Pharmaceutical Latest Developments
Table 142. BORA PHARMACEUTICALS Details, Company Type, Neurodegenerative Disease Area Served and Its Competitors
Table 143. BORA PHARMACEUTICALS Neurodegenerative Disease Product Offered
Table 144. BORA PHARMACEUTICALS Main Business
Table 145. BORA PHARMACEUTICALS Neurodegenerative Disease Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 146. BORA PHARMACEUTICALS Latest Developments
LIST OF FIGURES
Figure 1. Neurodegenerative Disease Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Neurodegenerative Disease Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Neurodegenerative Disease Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Neurodegenerative Disease Sales Market Share by Country/Region (2023)
Figure 8. Neurodegenerative Disease Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Neurodegenerative Disease Market Size Market Share by Type in 2023
Figure 10. Neurodegenerative Disease in Parkinson’s Disease
Figure 11. Global Neurodegenerative Disease Market: Parkinson’s Disease (2019-2024) & ($ Millions)
Figure 12. Neurodegenerative Disease in Huntington Disease
Figure 13. Global Neurodegenerative Disease Market: Huntington Disease (2019-2024) & ($ Millions)
Figure 14. Neurodegenerative Disease in Amyotrophic Lateral Sclerosis
Figure 15. Global Neurodegenerative Disease Market: Amyotrophic Lateral Sclerosis (2019-2024) & ($ Millions)
Figure 16. Neurodegenerative Disease in Alzheimer’s Disease
Figure 17. Global Neurodegenerative Disease Market: Alzheimer’s Disease (2019-2024) & ($ Millions)
Figure 18. Global Neurodegenerative Disease Market Size Market Share by Application in 2023
Figure 19. Global Neurodegenerative Disease Revenue Market Share by Player in 2023
Figure 20. Global Neurodegenerative Disease Market Size Market Share by Regions (2019-2024)
Figure 21. Americas Neurodegenerative Disease Market Size 2019-2024 ($ Millions)
Figure 22. APAC Neurodegenerative Disease Market Size 2019-2024 ($ Millions)
Figure 23. Europe Neurodegenerative Disease Market Size 2019-2024 ($ Millions)
Figure 24. Middle East & Africa Neurodegenerative Disease Market Size 2019-2024 ($ Millions)
Figure 25. Americas Neurodegenerative Disease Value Market Share by Country in 2023
Figure 26. United States Neurodegenerative Disease Market Size Growth 2019-2024 ($ Millions)
Figure 27. Canada Neurodegenerative Disease Market Size Growth 2019-2024 ($ Millions)
Figure 28. Mexico Neurodegenerative Disease Market Size Growth 2019-2024 ($ Millions)
Figure 29. Brazil Neurodegenerative Disease Market Size Growth 2019-2024 ($ Millions)
Figure 30. APAC Neurodegenerative Disease Market Size Market Share by Region in 2023
Figure 31. APAC Neurodegenerative Disease Market Size Market Share by Type in 2023
Figure 32. APAC Neurodegenerative Disease Market Size Market Share by Application in 2023
Figure 33. China Neurodegenerative Disease Market Size Growth 2019-2024 ($ Millions)
Figure 34. Japan Neurodegenerative Disease Market Size Growth 2019-2024 ($ Millions)
Figure 35. Korea Neurodegenerative Disease Market Size Growth 2019-2024 ($ Millions)
Figure 36. Southeast Asia Neurodegenerative Disease Market Size Growth 2019-2024 ($ Millions)
Figure 37. India Neurodegenerative Disease Market Size Growth 2019-2024 ($ Millions)
Figure 38. Australia Neurodegenerative Disease Market Size Growth 2019-2024 ($ Millions)
Figure 39. Europe Neurodegenerative Disease Market Size Market Share by Country in 2023
Figure 40. Europe Neurodegenerative Disease Market Size Market Share by Type (2019-2024)
Figure 41. Europe Neurodegenerative Disease Market Size Market Share by Application (2019-2024)
Figure 42. Germany Neurodegenerative Disease Market Size Growth 2019-2024 ($ Millions)
Figure 43. France Neurodegenerative Disease Market Size Growth 2019-2024 ($ Millions)
Figure 44. UK Neurodegenerative Disease Market Size Growth 2019-2024 ($ Millions)
Figure 45. Italy Neurodegenerative Disease Market Size Growth 2019-2024 ($ Millions)
Figure 46. Russia Neurodegenerative Disease Market Size Growth 2019-2024 ($ Millions)
Figure 47. Middle East & Africa Neurodegenerative Disease Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa Neurodegenerative Disease Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa Neurodegenerative Disease Market Size Market Share by Application (2019-2024)
Figure 50. Egypt Neurodegenerative Disease Market Size Growth 2019-2024 ($ Millions)
Figure 51. South Africa Neurodegenerative Disease Market Size Growth 2019-2024 ($ Millions)
Figure 52. Israel Neurodegenerative Disease Market Size Growth 2019-2024 ($ Millions)
Figure 53. Turkey Neurodegenerative Disease Market Size Growth 2019-2024 ($ Millions)
Figure 54. GCC Country Neurodegenerative Disease Market Size Growth 2019-2024 ($ Millions)
Figure 55. Americas Neurodegenerative Disease Market Size 2025-2030 ($ Millions)
Figure 56. APAC Neurodegenerative Disease Market Size 2025-2030 ($ Millions)
Figure 57. Europe Neurodegenerative Disease Market Size 2025-2030 ($ Millions)
Figure 58. Middle East & Africa Neurodegenerative Disease Market Size 2025-2030 ($ Millions)
Figure 59. United States Neurodegenerative Disease Market Size 2025-2030 ($ Millions)
Figure 60. Canada Neurodegenerative Disease Market Size 2025-2030 ($ Millions)
Figure 61. Mexico Neurodegenerative Disease Market Size 2025-2030 ($ Millions)
Figure 62. Brazil Neurodegenerative Disease Market Size 2025-2030 ($ Millions)
Figure 63. China Neurodegenerative Disease Market Size 2025-2030 ($ Millions)
Figure 64. Japan Neurodegenerative Disease Market Size 2025-2030 ($ Millions)
Figure 65. Korea Neurodegenerative Disease Market Size 2025-2030 ($ Millions)
Figure 66. Southeast Asia Neurodegenerative Disease Market Size 2025-2030 ($ Millions)
Figure 67. India Neurodegenerative Disease Market Size 2025-2030 ($ Millions)
Figure 68. Australia Neurodegenerative Disease Market Size 2025-2030 ($ Millions)
Figure 69. Germany Neurodegenerative Disease Market Size 2025-2030 ($ Millions)
Figure 70. France Neurodegenerative Disease Market Size 2025-2030 ($ Millions)
Figure 71. UK Neurodegenerative Disease Market Size 2025-2030 ($ Millions)
Figure 72. Italy Neurodegenerative Disease Market Size 2025-2030 ($ Millions)
Figure 73. Russia Neurodegenerative Disease Market Size 2025-2030 ($ Millions)
Figure 74. Spain Neurodegenerative Disease Market Size 2025-2030 ($ Millions)
Figure 75. Egypt Neurodegenerative Disease Market Size 2025-2030 ($ Millions)
Figure 76. South Africa Neurodegenerative Disease Market Size 2025-2030 ($ Millions)
Figure 77. Israel Neurodegenerative Disease Market Size 2025-2030 ($ Millions)
Figure 78. Turkey Neurodegenerative Disease Market Size 2025-2030 ($ Millions)
Figure 79. GCC Countries Neurodegenerative Disease Market Size 2025-2030 ($ Millions)
Figure 80. Global Neurodegenerative Disease Market Size Market Share Forecast by Type (2025-2030)
Figure 81. Global Neurodegenerative Disease Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Neurodegenerative Disease Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Neurodegenerative Disease Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Neurodegenerative Disease Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Neurodegenerative Disease Sales Market Share by Country/Region (2023)
Figure 8. Neurodegenerative Disease Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Neurodegenerative Disease Market Size Market Share by Type in 2023
Figure 10. Neurodegenerative Disease in Parkinson’s Disease
Figure 11. Global Neurodegenerative Disease Market: Parkinson’s Disease (2019-2024) & ($ Millions)
Figure 12. Neurodegenerative Disease in Huntington Disease
Figure 13. Global Neurodegenerative Disease Market: Huntington Disease (2019-2024) & ($ Millions)
Figure 14. Neurodegenerative Disease in Amyotrophic Lateral Sclerosis
Figure 15. Global Neurodegenerative Disease Market: Amyotrophic Lateral Sclerosis (2019-2024) & ($ Millions)
Figure 16. Neurodegenerative Disease in Alzheimer’s Disease
Figure 17. Global Neurodegenerative Disease Market: Alzheimer’s Disease (2019-2024) & ($ Millions)
Figure 18. Global Neurodegenerative Disease Market Size Market Share by Application in 2023
Figure 19. Global Neurodegenerative Disease Revenue Market Share by Player in 2023
Figure 20. Global Neurodegenerative Disease Market Size Market Share by Regions (2019-2024)
Figure 21. Americas Neurodegenerative Disease Market Size 2019-2024 ($ Millions)
Figure 22. APAC Neurodegenerative Disease Market Size 2019-2024 ($ Millions)
Figure 23. Europe Neurodegenerative Disease Market Size 2019-2024 ($ Millions)
Figure 24. Middle East & Africa Neurodegenerative Disease Market Size 2019-2024 ($ Millions)
Figure 25. Americas Neurodegenerative Disease Value Market Share by Country in 2023
Figure 26. United States Neurodegenerative Disease Market Size Growth 2019-2024 ($ Millions)
Figure 27. Canada Neurodegenerative Disease Market Size Growth 2019-2024 ($ Millions)
Figure 28. Mexico Neurodegenerative Disease Market Size Growth 2019-2024 ($ Millions)
Figure 29. Brazil Neurodegenerative Disease Market Size Growth 2019-2024 ($ Millions)
Figure 30. APAC Neurodegenerative Disease Market Size Market Share by Region in 2023
Figure 31. APAC Neurodegenerative Disease Market Size Market Share by Type in 2023
Figure 32. APAC Neurodegenerative Disease Market Size Market Share by Application in 2023
Figure 33. China Neurodegenerative Disease Market Size Growth 2019-2024 ($ Millions)
Figure 34. Japan Neurodegenerative Disease Market Size Growth 2019-2024 ($ Millions)
Figure 35. Korea Neurodegenerative Disease Market Size Growth 2019-2024 ($ Millions)
Figure 36. Southeast Asia Neurodegenerative Disease Market Size Growth 2019-2024 ($ Millions)
Figure 37. India Neurodegenerative Disease Market Size Growth 2019-2024 ($ Millions)
Figure 38. Australia Neurodegenerative Disease Market Size Growth 2019-2024 ($ Millions)
Figure 39. Europe Neurodegenerative Disease Market Size Market Share by Country in 2023
Figure 40. Europe Neurodegenerative Disease Market Size Market Share by Type (2019-2024)
Figure 41. Europe Neurodegenerative Disease Market Size Market Share by Application (2019-2024)
Figure 42. Germany Neurodegenerative Disease Market Size Growth 2019-2024 ($ Millions)
Figure 43. France Neurodegenerative Disease Market Size Growth 2019-2024 ($ Millions)
Figure 44. UK Neurodegenerative Disease Market Size Growth 2019-2024 ($ Millions)
Figure 45. Italy Neurodegenerative Disease Market Size Growth 2019-2024 ($ Millions)
Figure 46. Russia Neurodegenerative Disease Market Size Growth 2019-2024 ($ Millions)
Figure 47. Middle East & Africa Neurodegenerative Disease Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa Neurodegenerative Disease Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa Neurodegenerative Disease Market Size Market Share by Application (2019-2024)
Figure 50. Egypt Neurodegenerative Disease Market Size Growth 2019-2024 ($ Millions)
Figure 51. South Africa Neurodegenerative Disease Market Size Growth 2019-2024 ($ Millions)
Figure 52. Israel Neurodegenerative Disease Market Size Growth 2019-2024 ($ Millions)
Figure 53. Turkey Neurodegenerative Disease Market Size Growth 2019-2024 ($ Millions)
Figure 54. GCC Country Neurodegenerative Disease Market Size Growth 2019-2024 ($ Millions)
Figure 55. Americas Neurodegenerative Disease Market Size 2025-2030 ($ Millions)
Figure 56. APAC Neurodegenerative Disease Market Size 2025-2030 ($ Millions)
Figure 57. Europe Neurodegenerative Disease Market Size 2025-2030 ($ Millions)
Figure 58. Middle East & Africa Neurodegenerative Disease Market Size 2025-2030 ($ Millions)
Figure 59. United States Neurodegenerative Disease Market Size 2025-2030 ($ Millions)
Figure 60. Canada Neurodegenerative Disease Market Size 2025-2030 ($ Millions)
Figure 61. Mexico Neurodegenerative Disease Market Size 2025-2030 ($ Millions)
Figure 62. Brazil Neurodegenerative Disease Market Size 2025-2030 ($ Millions)
Figure 63. China Neurodegenerative Disease Market Size 2025-2030 ($ Millions)
Figure 64. Japan Neurodegenerative Disease Market Size 2025-2030 ($ Millions)
Figure 65. Korea Neurodegenerative Disease Market Size 2025-2030 ($ Millions)
Figure 66. Southeast Asia Neurodegenerative Disease Market Size 2025-2030 ($ Millions)
Figure 67. India Neurodegenerative Disease Market Size 2025-2030 ($ Millions)
Figure 68. Australia Neurodegenerative Disease Market Size 2025-2030 ($ Millions)
Figure 69. Germany Neurodegenerative Disease Market Size 2025-2030 ($ Millions)
Figure 70. France Neurodegenerative Disease Market Size 2025-2030 ($ Millions)
Figure 71. UK Neurodegenerative Disease Market Size 2025-2030 ($ Millions)
Figure 72. Italy Neurodegenerative Disease Market Size 2025-2030 ($ Millions)
Figure 73. Russia Neurodegenerative Disease Market Size 2025-2030 ($ Millions)
Figure 74. Spain Neurodegenerative Disease Market Size 2025-2030 ($ Millions)
Figure 75. Egypt Neurodegenerative Disease Market Size 2025-2030 ($ Millions)
Figure 76. South Africa Neurodegenerative Disease Market Size 2025-2030 ($ Millions)
Figure 77. Israel Neurodegenerative Disease Market Size 2025-2030 ($ Millions)
Figure 78. Turkey Neurodegenerative Disease Market Size 2025-2030 ($ Millions)
Figure 79. GCC Countries Neurodegenerative Disease Market Size 2025-2030 ($ Millions)
Figure 80. Global Neurodegenerative Disease Market Size Market Share Forecast by Type (2025-2030)
Figure 81. Global Neurodegenerative Disease Market Size Market Share Forecast by Application (2025-2030)
